HOWL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Werewolf Therapeutics Inc (HOWL) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The company's financial performance is weak, with declining net income, EPS, and gross margin. Hedge funds are selling heavily, and there are no positive trading signals or significant catalysts to support a bullish outlook. The technical indicators are neutral, and the options data shows minimal activity, indicating low trading sentiment.
The MACD is positive and expanding, suggesting mild bullish momentum. However, RSI at 65.775 is in the neutral zone, and moving averages are converging, indicating no clear trend. Key support is at 0.823, and resistance is at 0.878. Overall, the technical indicators are neutral.
NULL identified. No recent news or significant insider trading activity. Technical indicators are neutral, and there are no strong trading signals.
Hedge funds are selling heavily, with a 755.50% increase in selling activity over the last quarter. Financial performance is weak, with declining net income, EPS, and gross margin. No recent congress trading data or influential figure activity.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped to -$16,370,000, down 1.82% YoY. EPS decreased to -0.36, down 5.26% YoY. Gross margin dropped to 0, down 100% YoY. Overall, the financial performance is poor with no signs of improvement.
No analyst rating or price target data available for HOWL.
